p21CIP1 controls proliferating cell nuclear antigen level in adult cardiomyocytes

Molecular and Cellular Biology

Volumn 23, Issue 2, 2003, Pages 555-565

  Engel, Felix B ^a,d   Hauck, Ludger ^a   Boehm, Manfred ^b   Nabel, Elizabeth G ^b   Dietz, Rainer ^a   Von Harsdorf, Rüdiger ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLINE; CYCLOHEXIMIDE; DACTINOMYCIN; LACTACYSTIN; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CELL FREE SYSTEM; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; HEART MUSCLE CELL; IMMUNOBLOTTING; KNOCKOUT MOUSE; MALE; MITOSIS INHIBITION; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

ADENOVIRIDAE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CELL-FREE SYSTEM; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOHEXIMIDE; CYTOPLASM; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOBLOTTING; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; PLASMIDS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN SYNTHESIS INHIBITORS; S PHASE; UP-REGULATION;

ANIMALIA;

EID: 0037218849     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.2.555-565.2003     Document Type: Article

References (65)

1. Alder, H., M. Yoshinouchi, M. B. Prystowsky, P. Appasamy, and R. Baserga. 1992. A conserved region in intron 1 negatively regulates the expression of the PCNA gene. Nucleic Acids Res. 20:1769-1775.
2. Asada, M., T. Yamada, K. Fukumuro, and S. Mizutani. 1998. p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia 12:1944-1950.
3. Asada, M., T. Yamada, H. Ichijo, D. Delia, K. Miyazono, K. Fukumuro, and S. Mizutani. 1999. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18:1223-1234.
4. Becker, A. E. 2000. Primary heart tumors in the pediatric age group: A review of salient pathologic features relevant for clinicians. Pediatr. Cardiol. 21:317-323.
5. Beltrami, A. P., K. Urbanek, J. Kajstura, S. M. Yan, N. Finato, R. Bussani, B. Nadal-Ginard, F. Silvestri, A. Leri, C. A. Beltrami, and P. Anversa. 2001. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344:1750-1757.
6. Bravo, R., and H. Macdonald-Bravo. 1987. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J. Cell Biol. 105:1549-1554.
7. Brooks, G., R. A. Poolman, C. J. McGill, and J. M. Li. 1997. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J. Mol. Cell Cardiol. 29:2261-2271.
8. Capasso, J. M., S. Bruno, W. Cheng, P. Li, R. Rodgers, Z. Darzynkiewicz, and P. Anversa. 1992. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ. Res. 71:1379-1389.
9. Chen, I. T., M. L. Smith, P. M. O'Connor, and A. J. Fornace, Jr. 1995. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA. Oncogene 11:1931-1937.
10. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-388.
11. Choukroun, G., R. Hajjar, S. Fry, F. del Monte, S. Haq, J. L. Guerrero, M. Picard, A. Rosenzweig, and T. Force. 1999. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J. Clin. Investig. 104:391-398.
12. Coqueret, O., and H. Gascan. 2000. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275:18794-18800.
13. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
14. Di Cunto, F., G. Topley, E. Calautti, J. Hsiao, L. Ong, P. K. Seth, and G. P. Dotto. 1998. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280:1069-1072.
15. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
16. Ekholm, S. V., and S. I. Reed. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12:676-684.
17. Engel, F. B., L. Hauck, M. C. Cardoso, H. Leonhardt, R. Dietz, and R. von Harsdorf. 1999. A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ. Res. 85:294-301.
18. Flores-Rozas, H., Z. Kelman, F. B. Dean, Z. Q. Pan, J. W. Harper, S. J. Elledge, M. O'Donnell, and J. Hurwitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. USA 91:8655-8659.
19. Grove, B. K., V. Kurer, C. Lehner, T. C. Doetschman, J. C. Perriard, and H. M. Eppenberger. 1984. A new 185,000-dalton skeletal muscle protein detected by monoclonal antibodies. J. Cell Biol. 98:518-524.
20. Izumi, Y., S. Kim, T. Murakami, S. Yamanaka, and H. Iwao. 1998. Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats. Hypertension 31:50-56.
21. Kajstura, J., A. Leri, N. Finato, C. Di Loreto, C. A. Beltrami, and P. Anversa. 1998. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. USA 95:8801-8805.
22. Kang, M. J., and G. Y. Koh. 1997. Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. J. Mol. Cell Cardiol. 29:1767-1777.
23. Kearsey, J. M., P. J. Coates, A. R. Prescott, E. Warbrick, and P. A. Hall. 1995. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 11:1675-1683.
24. Kirshenbaum, L. A., M. Abdellatif, S. Chakraborty, and M. D. Schneider. 1996. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol. 179:402-411.
25. Kirshenbaum, L. A., and M. D. Schneider. 1995. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J. Biol. Chem. 270:7791-7794.
26. Krude, T., M. Jackman, J. Pines, and R. A. Laskey. 1997. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88:109-119.
27. Li, J. M., and G. Brooks. 1997. Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy. Am. J. Physiol. 273:H1358-H1367.
28. Li, R., S. Waga, G. J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537.
29. Limas, C. J., and C. Limas. 1978. DNA polymerases during postnatal myocardial development. Nature 271:781-783.
30. Liu, Y., and R. N. Kitsis. 1996. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J. Cell Biol. 133:325-334.
31. Liu, Y. C., and Y. W. Liu. 1992. Gene expression of proliferating cell nuclear antigen in rat brain. Biochem. Int. 28:129-136.
32. Mal, A., D. Chattopadhyay, M. K. Ghosh, R. Y. Poon, T. Hunter, and M. L. Harter. 2000. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J. Cell Biol. 149:281-292.
33. Marino, T. A., S. Haldar, E. C. Williamson, K. Beaverson, R. A. Walter, D. R. Marino, C. Beatty, and K. E. Lipson. 1991. Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells. Circ. Res. 69:1353-1360.
34. McGill, C. J., and G. Brooks. 1995. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc. Res. 30:557-569.
35. Megyesi, J., P. M. Price, E. Tamayo, and R. L. Safirstein. 1999. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc. Natl. Acad. Sci. USA 96:10830-10835.
36. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
37. Ottavio, L., C. D. Chang, M. G. Rizzo, S. Travail, C. Casadevall, and R. Baserga. 1990. Importance of introns in the growth regulation of mRNA levels of the proliferating cell nuclear antigen gene. Mol. Cell. Biol. 10:303-309.
38. Pines, J. 1995. Cyclins, CDKs and cancer. Semin. Cancer Biol. 6:63-72.
39. Poolman, R. A., R. Gilchrist, and G. Brooks. 1998. Cell cycle profiles and expressions of p21CIP1 and P27KIP1 during myocyte development. Int. J. Cardiol. 67:133-142.
40. Poolman, R. A., J. M. Li, B. Durand, and G. Brooks. 1999. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ. Res. 85:117-127.
41. Prelich, G., M. Kostura, D. R. Marshak, M. B. Mathews, and B. Stillman. 1987. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 326:471-475.
42. Prosperi, E. 1997. Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control. Prog. Cell Cycle Res. 3:193-210.
43. Quaini, F., E. Cigola, C. Lagrasta, G. Saccani, E. Quaini, C. Rossi, G. Olivetti, and P. Anversa. 1994. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ. Res. 75:1050-1063.
44. Rivett, A. J., S. Bose, P. Brooks, and K. I. Broadfoot. 2001. Regulation of proteasome complexes by gamma-interferon and phosphorylation. Biochimie 83:363-366.
45. Rumyantsev, P. P. 1977. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int. Rev. Cytol. 51:186-273.
46. Sell, C., C. D. Chang, J. Koniecki, H. M. Chen, and R. Baserga. 1992. A cryptopromoter is activated in the proliferating cell nuclear antigen gene of growth arrested cells. J. Cell. Physiol. 152:177-184.
47. Sen, A., P. Dunnmon, S. A. Henderson, R. D. Gerard, and K. R. Chien. 1988. Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J. Biol. Chem. 263:19132-19136.
48. Sever-Chroneos, Z., S. P. Angus, A. F. Fribourg, H. Wan, I. Todorov, K. E. Knudsen, and E. S. Knudsen. 2001. Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase. Mol. Cell. Biol. 21:4032-4045.
49. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
50. Shim, J., H. Lee, J. Park, H. Kim, and E. J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804-806.
51. Shivji, M. K., S. J. Grey, U. P. Strausfeld, R. D. Wood, and J. J. Blow. 1994. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr. Biol. 4:1062-1068.
52. Soonpaa, M. H., G. Y. Koh, L. Pajak, S. Jing, H. Wang, M. T. Franklin, K. K. Kim, and L. J. Field. 1997. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Investig. 99:2644-2654.
53. Studzinski, G. P., and L. E. Harrison. 1999. Differentiation-related changes in the cell cycle traverse. Int. Rev. Cytol. 189:1-58.
54. Tamamori, M., H. Ito, M. Hiroe, Y. Terada, F. Marumo, and M. A. Ikeda. 1998. Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am. J. Physiol. 275:H2036-H2040.
55. Torres, J., and R. Pulido. 2001. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276:993-998.
56. Vander Salm, T. J. 2000. Unusual primary tumors of the heart. Semin. Thorac. Cardiovasc. Surg. 12:89-100.
57. Vikstrom, K. L., T. Bohlmeyer, S. M. Factor, and L. A. Leinwand. 1998. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ. Res. 82:773-778.
58. von Harsdorf, R., L. Hauck, F. Mehrhof, U. Wegenka, M. C. Cardoso, and R. Dietz. 1999. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ. Res. 85:128-136.
59. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
60. Warbrick, E. 2000. The puzzle of PCNA's many partners. Bioessays 22:997-1006.
61. Warbrick, E., D. P. Lane, D. M. Glover, and L. S. Cox. 1995. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5:275-282.
62. Yoshizumi, M., W. S. Lee, C. M. Hsieh, J. C. Tsai, J. Li, M. A. Perrella, C. Patterson, W. O. Endege, R. Schlegel, and M. E. Lee. 1995. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J. Clin. Investig. 95:2275-2280.
63. Zezula, J., P. Casaccia-Bonnefil, S. A. Ezhevsky, D. J. Osterhout, J. M. Levine, S. F. Dowdy, M. V. Chao, and A. Koff. 2001. p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep. 2:27-34.
64. Zhou, B. P., Y. Liao, W. Xia, B. Spohn, M. H. Lee, and M. C. Hung. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245-252.
65. Zuppinger, C., M. C. Schaub, and H. M. Eppenberger. 2000. Dynamics of early contact formation in cultured adult rat cardiomyocytes studied by N-cadherin fused to green fluorescent protein. J. Mol. Cell Cardiol. 32:539-555.